Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N B Levy

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphomaG L DeNardo, S J DeNardo, D S Goldstein, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodiesS J DeNardo, G L DeNardo, L F O'Grady, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategyS J DeNardo, L F O'Grady, D J Macey, et al.
JAMA|September 9, 1983
T-lymphocyte subsets in lymph nodes from homosexual menR L Modlin, P R Meyer, F M Hofman, et al.
The American Journal of Surgical Pathology|February 27, 2001
Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomasW R Macon, N B Levy, P J Kurtin, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibodyG L DeNardo, S J DeNardo, K R Lamborn, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphomaG L DeNardo, S J DeNardo, D S Goldstein, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodiesS J DeNardo, G L DeNardo, L F O'Grady, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategyS J DeNardo, L F O'Grady, D J Macey, et al.
JAMA|September 9, 1983
T-lymphocyte subsets in lymph nodes from homosexual menR L Modlin, P R Meyer, F M Hofman, et al.
The American Journal of Surgical Pathology|February 27, 2001
Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomasW R Macon, N B Levy, P J Kurtin, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibodyG L DeNardo, S J DeNardo, K R Lamborn, et al.
Pageof 7